← Eichor
Study identifier: NCT06157437 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

An Exploratory Study of Focal Pulse Ablation System in the Treatment of Atrial Arrhythmia

Condition: Typical Atrial Flutter · Atrial Fibrillation (AF)  ·  Sponsor: Hangzhou Dinova EP Technology Co., Ltd

PhaseNA
Planned participants10
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a prospective, single-group clinical study. The objective is to evaluate the safety and efficacy of focal pulse ablation system in the treatment of typical atrial flutter.

This description comes directly from the study's public registry record.

Talk to the study team

Haitao Yang  ·  +8637158680341  ·  dinova_ep@dnaeps.com

Always discuss trial participation with your own doctor first.

Locations (1)

Fuwai Hospital, Chinese Academy of Medical SciencesBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06157437